4.5 Article

HEME OXYGENASE 1, BENEFICIAL ROLE IN PERMANENT ISCHEMIC STROKE AND IN GINGKO BILOBA (EGB 761) NEUROPROTECTION

Journal

NEUROSCIENCE
Volume 180, Issue -, Pages 248-255

Publisher

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.neuroscience.2011.02.031

Keywords

bioactive; complementary and alternative medicine; hemin; natural supplements; neurologic disorders

Categories

Funding

  1. National Institutes of Health [K99AT004197, R21AT001836, R21AT005085]

Ask authors/readers for more resources

Ginkgo biloba extract, EGb 761, a popular and standardized natural extract, contains 24% ginkgo-flavonol glycosides and 6% terpene lactones. EGb 761 is used worldwide to treat many ailments, and although a number of studies have shown its neuroprotective properties, the mechanisms of action have not been elucidated fully. We hypothesize that EGb 761 and some of its bioactive components [Bilobalide (BB), Ginkgolide A (GA), Ginkgolide B (GB), and Terpene Free Material (TFM)] could provide neuroprotection in ischemic conditions through heme oxygenase 1 (HO1). Mice were subjected to permanent distal middle cerebral artery occlusion (pMCAO) and survived for 7 days. HO1 knockout (HO1(-/-)) mice showed significantly higher (P < 0.05) infarct volume and Neurologic Deficit Scores (NDS) as compared to their wildtype (WT) counterparts. In another cohort, WT mice subjected to pMCAO and treated at 4 h of pMCAO with 100 mg/kg EGb 761, 6 mg/kg BB, GA, GB, or 10 mg/kg TFM showed significantly lower (P<0.05) infarct volumes (BB; 29.0 +/- 3.9%, GA; 31.3 +/- 4.0%, GB; 32.0 +/- 3.8%, TFM; 32.5 +/- 3.5%, and EGb 761; 27.4 +/- 4.5%) than those in the vehicle-treated mice (46.0 +/- 3.7%). Similarly, NDS were lower in BB; 7.1 +/- 1.8, GA; 7.4 +/- 2.1, GB; 7.9 +/- 1.8, TFM; 7.7 +/- 1.7, and EGb 761; 6.8 +/- 2.0 groups as compared with the vehicle-treated group (13.8 +/- 1.5). Interestingly, the protective effect of EGb 761 was essentially lost when HO1 knockout mice were treated with EGb 761. In another cohort, HO1, vascular endothelial growth factor (VEGF) and endothelial nitric oxide synthase (eNOS) protein levels in the brain cortices appeared to be higher in EGb 761 and BB but not in GA, GB and TFM treated groups. Together, these results suggest that HO1 plays, at least in part, an important role in the neuroprotective mechanism of EGb 761 and in delayed ischemia. Targeting this pathway could lead to neuroprotective agents against ischemic stroke. (c) 2011 IBRO. Published by Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available